AstraZeneca To Collaborate With Pieris Pharmaceuticals In Development Of New Respiratory Disease Treatment
May 03, 2017 at 13:43 PM EDT
Pieris Pharmaceuticals, Inc. has entered into a collaboration with AstraZeneca PLC for $45 million upfront and the possibility of an additional $2.1 billion more in milestone attainments plus royalties on sales.
